Tirzepatide (TRZ GLP-1)
Tirzepatide (TRZ GLP-1)
Tirzepatide (TRZ GLP-1)
  1. Tirzepatide (TRZ GLP-1)
  2. Tirzepatide (TRZ GLP-1)
  3. Tirzepatide (TRZ GLP-1)

Tirzepatide (TRZ GLP-1)

$35.00 – $220.00

Tirzepatide is an antidiabetic medication used to treat type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections

SKU: 3f8fcb98676b Category:

Chemical Information

Molecular Formula: C225H348N48O68
Molecular Weight: 4813.56 g/mol

Research Applications

TRZ GLP-1’s unique action on both GIP and GLP-1 receptors provides insights into pathways related to glucose metabolism and insulin sensitivity in laboratory settings.

Disclaimer

Tirzepatide is intended solely for laboratory research and is not for human consumption. Any patented status of Tirzepatide must be respected by researchers.

Patent and Trademark Acknowledgment

“Tirzepatide is a patented compound developed by Eli Lilly and marketed under the brand name Mounjaro®. Any reference to tirzepatide is solely for informational and educational purposes regarding its availability for laboratory research only. This product is not manufactured, endorsed, or approved by Eli Lilly.”

Suggested References

Frias, J.P., et al. “Dual GIP and GLP-1 Agonists for Metabolic Regulation” (New England Journal of Medicine, 2021).

Weight

10mg* 10vials, 15mg* 10vials, 20mg* 10vials, 30mg* 10vials, 5mg* 10vials, 60mg* 10vials

Related products